Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations

Clinical trial NCT01024413 · COMPLETED

Trial details

NCT number: NCT01024413
Sponsor: Chinese Society of Lung Cancer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Thoracic Neoplasms

Start date: 2009-07-01
Primary completion: 2015-06-01
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.